This week's View focuses on the coronavirus disease 2019 (COVID-19) resources on ACC.org, including key points from articles about the Emergency Use Authorization for the use of convalescent plasma to treat COVID-19; the potential cardioprotective effects of influenza vaccines in the context of the COVID-19 pandemic; the risk factors, incidence, and outcomes associated with in-hospital cardiac arrest and cardiopulmonary resuscitation in critically ill adults with COVID-19; and the observed mortality incidence among patients with COVID-19 within 90 days of receiving extracorporeal membrane oxygenation support.

Subscribe on Apple Podcasts | Subscribe on Google Play

Clinical Topics: Acute Coronary Syndromes, Arrhythmias and Clinical EP, Cardiac Surgery, COVID-19 Hub, Diabetes and Cardiometabolic Disease, Heart Failure and Cardiomyopathies, Invasive Cardiovascular Angiography and Intervention, Noninvasive Imaging, Prevention, Pulmonary Hypertension and Venous Thromboembolism, Vascular Medicine, Implantable Devices, SCD/Ventricular Arrhythmias, Atrial Fibrillation/Supraventricular Arrhythmias, Cardiac Surgery and Arrhythmias, Cardiac Surgery and Heart Failure, Acute Heart Failure, Pulmonary Hypertension, Interventions and ACS, Interventions and Imaging, Interventions and Vascular Medicine, Angiography, Nuclear Imaging, Hypertension

Keywords: EaglesEyeView, Acute Coronary Syndrome, Acute Kidney Injury, Arrhythmias, Cardiac, Cardiac Surgical Procedures, Cardiopulmonary Resuscitation, Coronary Angiography, Coronavirus, severe acute respiratory syndrome coronavirus 2, COVID-19, ACC COVID-19 Podcast, Critical Illness, Drug Approval, Endothelial Cells, Extracorporeal Membrane Oxygenation, Heart Arrest, Heart Failure, Hospital Mortality, Immunity, Humoral, Immunoglobulins, Influenza Vaccines, Influenza, Human, Intensive Care Units, Length of Stay, Lung Diseases, Myocardial Infarction, Patient Discharge, Peptidyl-Dipeptidase A, Plasma, Post-Exposure Prophylaxis, Public Health, Primary Prevention, Respiratory Distress Syndrome, Respiratory Tract Infections, Resuscitation Orders, Risk Factors, Secondary Prevention, Thrombosis, Treatment Outcome, Troponin, United States Food and Drug Administration, Vascular Diseases, Diagnostic Imaging, Hypertension, Pulmonary

< Back to Listings